z-logo
open-access-imgOpen Access
Effects of peroxisome proliferator-activated receptor-γ agonists on the generation of microparticles by monocytes/macrophages
Author(s) -
Tommaso Neri,
Cinzia Cordazzo,
Yuri Carmazzi,
Silvia Petrini,
Cristina Balìa,
Fabio Stefanelli,
Angela Amoruso,
Sandra Brunelleschi,
Maria Cristina Breschi,
Roberto Pedrinelli,
Pierluigi Paggiaro,
Alessandro Celi
Publication year - 2012
Publication title -
cardiovascular research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.774
H-Index - 219
eISSN - 1755-3245
pISSN - 0008-6363
DOI - 10.1093/cvr/cvs125
Subject(s) - microparticle , tissue factor , chemistry , annexin , rosiglitazone , peroxisome proliferator activated receptor , phosphatidylserine , cd36 , pharmacology , receptor , microbiology and biotechnology , endocrinology , medicine , biology , apoptosis , biochemistry , coagulation , phospholipid , membrane , astrobiology
Microparticles are membrane vesicles shed by cells upon activation and/or apoptosis. Microparticles are involved in several processes, including blood coagulation and thrombosis. In addition to their role in the regulation of lipid metabolism, peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists exert other effects, both dependent on and independent of PPAR-γ activation. Some PPAR-γ agonists have been linked to an increased risk of thrombotic diseases. We aimed to investigate the potential role of PPAR-γ agonists on the generation of procoagulant microparticles by human monocytes/macrophages.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom